A groundbreaking study finds a strong link between air pollution and dementia risk, with pollutants like PM2.5 and soot leading to increased chances of developing the disease. With millions affected globally, urgent action is needed to tackle this hidden threat.
A new monoclonal antibody called clesrovimab has been recommended for infants to prevent RSV, stirring debate among health experts and advocates. The FDA approved the treatment just weeks ago.
